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Abstract
Objective A case-control study of patients with pneumonia was conducted to investigate
whether wheezing diseases could be a risk factor.
Methods A random sample was taken from a general university hospital in S. Paulo City
between March and August 1994 comprising 51 cases of pneumonia paired by
age and sex to 51 non-respiratory controls and 51 healthy controls. Data collec-
tion was carried out by two senior paediatricians. Diagnoses of pneumonia and
presence of wheezing disease were independently established by each
paediatrician for both cases and controls. Pneumonia was radiologically con-
firmed and repeatability of information on wheezing diseases was measured.
Logistic regression analysis was used to identify risk factors.
Results Wheezing diseases, interpreted as proxies of asthma, were found to be an im-
portant risk factor for pneumonia with an odds ratio of 7.07 (95%CI= 2.34-
21.36), when the effects of bedroom crowding (odds ratio = 1.49 per person,
95%CI= 0.95-2.32) and of low family income (odds ratio = 5.59 against high
family income, 95%CI= 1.38-22.63) were controlled. The risk of pneumonia
attributable to wheezing diseases is tentatively calculated at 51.42%.
Conclusion It is concluded that at practice level asthmatics should deserve proper surveil-
lance for infection and that at public health level pneumonia incidence could be
reduced if current  World Health Organisation’s guidelines were reviewed as to
include comprehensive care for this illness.
Asthma, complications. Pneumonia. Case-control studies.
Resumo
Objetivo Investigar, através de um estudo caso-controle de pacientes com pneumonia, se
as doenças chiadoras poderiam constituir-se em fator de risco.
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Métodos De um hospital universitário, na cidade de São Paulo, Brasil, entre março e
agosto de 1994, foi tomada uma amostra de 51 casos de pneumonia pareados
por sexo e idade a 51 controles sadios e 51 controles não respiratórios. O
diagnóstico de pneumonia e a presença de doença chiadora foram investigados
de forma independente por cada pediatra tanto para casos quanto para
controles. Foi confirmada pneumonia radiologicamente e a repetibilidade da
informação sobre doença chiadora foi medida. Foi utilizada regressão logística
para identifição de riscos.
Resultados As doenças chiadoras, entendidas como representantes de asma, mostraram
ser importante fator de risco para pneumonia, com um odds ratio de 7,07
(IC95%= 2,34-21,36), controlados os efeitos de aglomeração no quarto de
dormir (odds ratio de 1,49 por pessoa a mais no quarto, IC95%= 0,95-2,32) e
a baixa renda familiar (odds ratio de 5,59 contra alta renda familiar, IC95%=
1,38-22,63). O risco atribuível às doenças chiadoras foi calculado de forma
exploratória em 51,42%.
Conclusão Conclui-se que os clínicos devem ter atenção sobre asmáticos para o risco de
infecção e que ao nível da saúde pública a incidência de pneumonia poderia ser
reduzida se as orientações atuais da Organização Mundial da Saúde pudessem
ser revistas para oferecer atenção integral para os doentes.
Asma, complicações. Pneumonia, etiologia. Estudos de casos e controles.
INTRODUCTION
The major approach in the investigation of asthma
and infection refers to the role of the latter as regards
either the inception or the acute manifestations of
the former. Accordingly, the effects of infection on
the development of asthma and bronchial hyper-
reactivity have been exhaustively explored covering
both viral and bacterial infections5,7,13-18,20,23,25,27,30,32,
while the reciprocal, namely the effects of asthma
on the development of infection, has been overlooked.
Clough and Dow3, in an Editorial to Clinical Allergy
in 1987, raised the subject but limited themselves to
remark that a “hypothesis is that asthmatics may be
more at risk of developing respiratory infections”.
Stenius-Aarniala29 in a review of the subject for
Chest, maintained the infection-towards-asthma
approach with the statement that “bacterial infections
of nasal sinuses and bronchi are probably secondary
to mucosal edema, hypersecretion, bronchospasm
and mucocilliary dysfunction. There is no evidence
that they are the primary cause of an exacerbation of
asthma. It is possible that some bacterial infections
will limit themselves if the pathologic state of the
mucosa is reversed and its normal function restored
by the antiasthmatic medication”. Thus they
acknowledged that an impaired function could
predispose to infection though not focusing further
on the matter. Indeed, bronchoalveolar lavage studies
in asthmatics suggest that the respiratory lining
becomes both susceptible and receptive to infection
as defence is impaired2 and a culture medium is
formed by excessive mucus secretion8. Moreover,
these studies suggest that an adequate control of
asthma can revert this situation6.
The interest in investigating the role of asthma in
the development of infection might have been
discouraged by the results of studies focused on
asthma attacks which deny evidence of any associa-
tion between them and infection. Hudgel et al.11,
studying adult patients in 1979, showed that even
though asthmatics had chronic colonisation of the
respiratory tract with pathogenic bacteria, their
presence did not yield a greater frequency of asthma
attacks. Likewise, Graham et al.10 in a clinical trial
with patients under asthma attacks, found that
prescription of amoxycillin would not improve
recovery. More recent studies, as the one conducted
by Gbadero et al.9, in Nigeria, come to the same
conclusion, i.e., that routine antibiotic therapy should
be avoided. Nonetheless, one should notice that lack
of association between infection and asthma attacks
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does not preclude a possible association between
infection and asthma in the long run. It should also
be noticed that the recurrent what-infection-does-to-
asthma approach is maintained.
Recent studies have suggested that asthmatic
children might be more liable to respiratory
infection. Porro et al.22, conducting a cross-sectional
study with 2,304 schoolchildren in Italy, found that
the odds ratio for upper respiratory infection was
2.20 (95% CI = 1.44 to 3.35) for asthmatics; Infant-
Rivard12, comparing 457 asthmatics to an equal
number of controls matched by age and residence
areas, found that the frequency of previous pneu-
monia was 3.12 (95% CI = 1.92 to 5.09) times
greater in asthmatics than in their controls; and
Victora et al.31, investigating risk factors for pneu-
monia in a case-control study with 510 infants less
than 2 years old, found that the odds ratio for pneu-
monia was 1.75 (95% CI= 1.16 to 2.63) among
infants with a history of wheezing treated at home
and 2.99 (95% CI = 1.53 to 5.83) among infants
with a history of wheezing treated at hospital. A
previous study21 analysed 18,255 records of paedia-
tric outpatient clinics and it was found that among
the 1,371 cases of double diagnosis when the main
diagnosis was asthma the odds for pneumonia were
4.98 (95% CI = 3.49 to 7.10). The same study re-
viewed 84,143 cases in death of children under five
years of age and found that wheezing diseases and
pneumonia were associated with an odds ratio of
3.0 (95% CI = 2.50 to 3.59).
The present study was conceived to further
investigate this evidence. To avoid disputes over the
diagnosis of asthma the presence of a non-infectious
wheezing disease was chosen as a broader approach
likely to cover the clinical conditions characterised by
some degree of underlying bronchial hyper-reactivity
and/or atopy.
MATERIAL AND METHODS
A teaching hospital of S. Paulo city based case-control
study was designed as to compare paediatric cases of pneu-
monia with controls paired by age and sex. Two types of
controls were devised for each case of pneumonia: one
patient under treatment for a non-respiratory disease and
one healthy child brought to hospital either to escort a
diseased child or for routine development surveillance in
an outpatient clinic. All children were registered as users
of the local health system which comprises local health
centres and out and inpatient services of the hospital at a
referral level. The hospital studied is a general hospital
that offers services to the academic community and to the
general population of a delimited catchment area covering
the neighbouring boroughs. Thus, the socio-economic
composition of the users’ community covered a wide ran-
ge of people from slum dwellers to university students
and teachers.
The sample size was calculated according to Schlessel-
man's24 directions for studies taking two controls for each
case.  A level of significance of 5% and a power of 90%
were taken and assumptions regarding frequency of
wheezing diseases and odds ratio's were drawn from
previous experience21 (15% and 4, respectively, were taken
as a basis for calculation). Thus a minimum number of 43
triplets was established. The two control strategy was
aimed at achieving a pool of controls with a wide spectrum
for all the variables measured.
Case selection: An assessment of the hospital demand
suggested that a four month period should suffice to gather
data. Accordingly all cases of pneumonia in children (age
limit of 10 years) diagnosed either in outpatient clinics
(referred patients) or in the casualty department (patients
skipping primary care to seek medical assistance directly
from the hospital) from March (end of summer) to July
(mid-winter) 1994 were considered for entry. Only cases
of community acquired pneumonia with no previous
treatment were accepted. Diagnosis was confirmed by
clinical and radiological investigation.
Control identification: For each case entering the
study, a control was immediately sought among other
children present at the hospital. A tolerance level of 3
months for children under 2 years of age and of 6 months
for children older than that was established for the purpose
of matching ages.
Data collection: Given parental consent, two senior
paediatricians appointed by the University Paediatric
Department independently applied standardised protocols
to characterise the presence of pneumonia and wheezing
diseases in both cases and controls. Thus, interobserver
variation in the conclusions about these conditions was
controlled and the investigation of their presence was made
in the same fashion as that of their absence. Controls were
spared from radiological investigation on ethical grounds.
Field supervision provided by the authors checked
compliance with standard observation procedures. A
random sample of 20% of all children studied was taken
to assess repeatability of the data collected to investigate
history of wheezing.
Data analysis: An initial univariate approach compa-
red means or modes, as applicable (ANOVA or Kruskal-
Wallis, respectively), of variables in cases and controls.
Variables found with significant differences between ca-
ses and controls were considered for a multivariate logistic
regression to assess the possible risk of exposition to
wheezing diseases in the presence of pneumonia whon
potential confounders were controlled. Children were
considered as exposed to wheezing disease if they could
be labelled current wheezers according to either a previous
medical diagnosis of asthma and at least one episode of
wheezing in the last 12 months or a history of wheezing
and at least 3 episodes responsive to bronchodilator, out
of cold spells, in the last 12 months.
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Some conditions, thought likely to interfere with the
relationship studied, were computed into new variables
from original data and were also considered for the logistic
model:
1. Environmental pollution: ranging from 0 to 4, this
was computed as the sum of the presence of ex-
position to fumes from wood or coal cookers, low
exposure of child’s bedroom to sunlight, presence
of humidity and mould within the house, and
presence of fumes, smells and vapours from indus-
trial plants in the neighbourhood of the child’s house;
2. Personal history of atopy: ranging from 0 to 2, this
was computed as the sum of positive history of
rhinitis and eczema, provided that at least one
episode had been referred during the preceding 12
months;
3. Family history of atopy: computed as the number
of first degree relatives with a positive history of
atopy;
4. Family history of asthma: computed as the number
of first degree relatives with a positive history of
asthma.
RESULTS
Data collection effectively took place between 14
March and 2 August, 1994. Fifty one cases of pneu-
monia met the entry criteria and were duly paired to
controls. Table 1 shows age and sex distribution of
the study groups.
No significant difference in race was detected
among cases and controls and 114 (76%) of the 153
children studied were Caucasian. Likewise, no
difference in nutritional status was found, assessment
being carried out as recommended by World Health
Organization guidelines19. Causes for medical
attendance among non-respiratory controls were
mainly diarrhoea (52.94%), followed by trauma
(9.8%), meningitis (3.92%), arthritis (3.92%) and
otitis with no upper respiratory disease (3.92%).
All the 51 cases of pneumonia were diagnosed
as bacterial in origin, 40 (78.4%) were admitted to
hospital for treatment and the others were treated as
outpatients. Radiological images showed lobar
consolidation in 15 patients (29.4%), patchy alveolar
consolidation in 41(80.4%), atelectasis in 3(5.9%),
pleural effusion in 8(15.7%) and hyperaeration in
1(2%). Degree of clinical severity, assessed by level
of dyspnoea, was mild for 46 patients (90%),
moderate for 4(7.8%) and severe for 1 patient (2%).
None required intensive care.
Re-application of the protocol to investigate the
history of previous exposition to wheezing disease
in 30 randomly selected children involved 12 cases
(40%), 13 non-respiratory controls (43%), and 5
healthy controls (17%). The item by item agreement
ranged from 11.1% (Kappa =0, for the question on
number of wheezing episodes during the last 12
months) to 100% (Kappa =1, for the question on
wheezing response to smells and fumes). Classi-
fication of the child as exposed or not exposed to
wheezing disease had an agreement  of  80.0%
(Kappa = .60, 24 of the 30 children). The time lag
between the first and second interviews was 45 days
on average and some children had indeed changed
their status during this period.
Univariate analysis of 120 variables detected 10
instances of significant differences between the study
groups, as listed in Table 2.
All these variables, along with the previously
defined potential confounders, were considered for
a logistic model. Family income was recorded to three
ranks of the observed distribution. The analysis was
carried out by the conditional backward stepwise
method establishing .05 as minimum significance
level for a variable entering the model and .10 for
one exiting. Table 3 shows the results of the first step
of the analysis where all variables are forced into the
model regardless the significance level and the results
of the last step in which only the variables with due
significance level are maintained.
The final model was found to be consistent
(Goodness-of-fit X2 = 101.71, p =.52). Comparison
of the initial and final models suggests that although
parental education, environmental pollution, family
history of asthma, and personal history of atopy (odds
ratios >1) did not achieve significance level in the
sample studied they might be risk factors detectable
in larger samples. Such an approach should also help
towards the elucidation of the paradoxical suggestion
that events like exposition to smokers, atopy in
family, and bad housing conditions could be
protective to pneumonia (odds ratios < 1).
Taking the calculated odds ratio for current
wheezers as an approximation to the relative risk and
the frequency of wheezing diseases among controls
Table 1- Age in months of the children studied
according to sex and study group.
Study Male Female
group Mean S. Error n Mean S. Error n
Cases 18.09 3.47 24 28.12 3.73 27
Non-respir. 18.42 3.40 24 28.90 3.85 27
Controls
Healthy 17.99 3.54 24 27.63 3.75 27
Controls
Total 18.16 1.98 72 28.22 2.15 81
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Table 2 - Frequencies/mean values of variables with significant differences among the groups studied.
Study group Statistics*
Variables Cases Non-respiratory Healthy
controls controls
Housing
•Lodging type x2=7.13
Familiy 43 42 50 p= .02
Collective 8 9 1
•Sanitation x2=13.79
Toilette inside 41 36 49 p= .00
Toilette outside 10 13 1
No toilette 0 2 1
Environment
•Smokers at home F= 2.96
Mean nº of people .84 1.10 .59 p=  . 05
•Bedroom crowding F= 7.46
Mean nº of people 4.02 3.80 2.92 p= .00
Economic & Social status
•Family income
Monthly averege 269.15 341.52 952.40 F= 12.93
(US$) p= .00
•Parental education
llliterate father 10 6 1 x2= 31.60
p= .00
llliterate mother 12 7 3 x2= 31.18
p= .00
Personal medical history
•History of laryngitis 23 7 12 x2= 12.43
p = .00
•Previous diagnosis of asthma 19 7 11 x2= 7.93
p = .01
•Current wheezer 23 10 8 x2= 13.17
p = .00
* Kruskal-Wallis or ANOVA, as applicable.
Table 3 - Results of logistic regression.
Initial model Final model
Variables Odds 95% CI Signif. Odds 95% CI Signif.
ratio Level ratio level
llliterate mother 5.05 000.11 - 0.40
(contrast=university educated) 222.50
llliterate father 1.54 000.01 - 0.73
(contrast=university educated) 157.59
Environ. pollution 1.66 0.70-3.92 0.24
Nº asthmat. relatives 1.66 0.34-8.16 0.52
Atopic child 1.29 0.35-4.74 0.70
Age in months 0.98 0.95-1.01 0.36
Nº smokers at home 0.81 0.45-1.46 0.48
Sex (if male) 0.68 0.19-2.40 0.55
Nº Atopic relatives 0.57 0.21-1.56 0.27
Toilette outside 0.56 0.11-2.72 0.47
(contrast=inside)
Hist. laryngitis 0.48 0.06-3.47 0.47
Collective lodgings 0.29 0.05-1.62 0.16
(contrast=individual)
Family income (contrast-high) 0.17 0.04
Low 6.36 0.87-46.28 0.06 5.59 1.38-22.63 0.01
Intermediate 2.36 0.40-13.90 0.34 2.44 0.59-9.98 0.21
Bedroom crowding 1.68 0.88-3.21 0.11 1.49 0.95-2.32 0.07
Current wheezer 17.22 2.26-21.47 0.00 7.07 2.34-21.36 0.00
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as an indicator of its frequency in the population, a
tentative estimate of attributable risk of 51.42% may
be calculated1, this being roughly the expected
reduction in the incidence of pneumonia if wheezing
disease effects are withheld.
COMMENTS AND CONCLUSION
The present study has found that wheezing diseases
are a major risk factor for the development of pneu-
monia which stands side by side with other known
risk factors such as crowding and low family income.
Moreover, the multivariate analysis provided evidence
that its effects on the development of pneumonia are
independent of and have a multiplicative action on the
effects of these known risk factors: a wheezing child
has a 7 times greater chance of developing pneumo-
nia than a non-wheezing child under the same
conditions of family income and bedroom crowding,
and the chances of pneumonia for a wheezing child
with low family income who sleeps in a room with
another person are 58.8 (5.59 X 1.49 X 7.07) times
greater than they are for a non-wheezing child of high
family income who sleeps alone.
Even though it could be argued that not all
wheezing children are asthmatics4, as the study design
excluded infectious causes of wheezing it is likely
that the wheezers identified are either asthmatics in
the strict sense of bronchohyperreactivity and atopy26,
or are cases of similar pathological conditions whose
clinical presentations receive different clinical labels.
Most of these cases would benefit from a prompt and
straightforward recognition of the asthmatic
condition as they would get better with anti-asthmatic
therapy28.
The calculated attributable risk of 51.42% might
not be a fair assessment of the possible impact of
the control of the wheezing diseases on the inci-
dence of pneumonia because it was not drawn from
a random population sample but from a hospital
based study. Nonetheless, the community assisted
by the Teaching Hospital of the University of S.
Paulo was fairly represented in the sample studied
and one would not expect this community to differ
very greathy from the general population of S. Paulo
City as a whole. Indeed, as a general hospital, the
University Hospital is spared the selection bias
common to specialised hospitals and yet, having a
defined catchment area for general medical assis-
tance, it is likely to faithfully to represent at least
this latter community. Possible differences between
this community and the rest of the population would
be mainly of a geographical nature as the gamut of
the occurrence of all the independent variables was
duly covered by the enlarged range provided by the
two control strategy.
The present findings should not only advise
clinical practice, recommending surveillance of
asthmatics with regard to the possible development
of pneumonia, but they also suggest the need for a
review of the current World Health Organization’s
guidelines for the control of acute respiratory infec-
tions in children, a major world-wide challenge to
public health. These guidelines33 focus on screening
and case management of pneumonia while the present
findings suggest that comprehensive care able to
assist chronic illnesses such as wheezing diseases
could contribute with a considerable reduction of the
incidence of pneumonia, in some same places
achieving levels of up to 50%.
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